TP53 and acute myeloid leukemia: To determine whether upregulation of erythroid-associated transcription was a more widespread phenomenon in TP53-mutant AML, we investigated erythroid–myeloid-associated transcription in the BeatAML and The Cancer Genome Atlas (TCGA) cohorts26,27.